Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
After almost a decade on antiretroviral therapy, half of study participants still had HIV in immune cells in their brain and spinal fluid.
HIV-related stigma is reported to have harsh effects on cognition.
That’s compared with a control group of HIV-negative individuals in a small study.
A research team has sought to address the critical lack of treatment guidelines for addressing HIV’s complex effects on aging.
Such effects have a downstream impact on the real-world functioning of people with HIV.
These two factors may exacerbate brain declines in people with HIV.
A major mitigating factor may be treating HIV with antiretrovirals.
This is according to a survey conducted in South Africa.
Middle-aged people living with the virus have a higher rate of silent cerebral small-vessel disease than their HIV-negative peers.
A recent small study found that pot smokers had less evidence of inflammation associated with cognitive decline.
The authors of a recent study hypothesize that HIV’s initial attack on the brain may be responsible for subsequent cognitive decline.
Researchers identified this advancing risk after controlling for expected cognitive decline based on age.
A new study advises looking at factors such as depression, anxiety and unemployment before pointing the finger at cognitive impairment.
The antidepressant Paxil (paroxetine) led to moderate improvements among people with HIV-related neurocognitive dysfunction.
The severity of liver fibrosis is associated with cognitive dysfunction independent of hepatitis C or HIV status.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.